Precision Medicine
Comprehensive Genome based decisions
Why should you opt for genomic testing?

Every cancer is unique. It is a complex disease, coupled with tumor heterogeneity and multiple molecular alterations occurring in the genes, simultaneously. We at Personome, believe that the key to understanding individual cancers is through exploring the individual genes.

Knowing the cancer type is not enough as the molecular characteristics of your cancer differ from other patient's cancer even if the cancer type is same. The molecular alterations in genes may include different types such as single nucleotide variations, structural variations, gene fusions and rearrangements, exon skipping events, methylation, changes in gene expression and microsatellite instability. The type of genomic alteration in the tumor decides how the tumor will grow and influence the patient’s response to treatment. Hence, emerging therapeutic strategies warrant a comprehensive assessment of oncogenic landscape achievable through genomic profiling.

The molecular insights gained could make a drastic change in the way we look at individual cancers. It can potentially provide rapid diagnosis, help in identification of therapeutic options and improve clinical outcomes.

How do we do it?

We use latest molecular technologies to analyze the patient's unique genetic make-up which include the defects responsible for cancer. This helps gain knowledge about how the cancer will respond to certain therapies.

Our advanced proprietary Cancer Analytics Platform (CAP) enables us to detect the actionable causal molecular alterations in the patient's cancer samples in faster and more accurate ways, with our knowledgebase providing the most relevant scientific data. It thus helps us generate a personalized genomic profile for each cancer patient using comprehensive genomic analysis - in terms of genetic variations, disease and possible treatment options. Integration of evidence based data, clinical and drug data makes it a reliable source.

CAP will aid physicians in -

  • Knowing which molecular changes in patients could be responsible for the development of cancer
  • Knowing the potentially beneficial therapies to treat patients' cancer
  • Receiving information about a clinical trial in which patient can participate
  • Reducing uncertainty about which treatments to try first
  • Knowing and avoiding adverse effects of 'not so effective' drugs

Features of our personalized report -

  • Molecular Alterations: Molecular alterations found in cancer analytics platform
  • Therapeutic Indications: Likely Clinical Indications based on the genomic landscape
  • Clinical Trials: Suggested clinical trials based on the disease details
  • Supporting Information: Includes published data related to gene, therapies and biomarkers along with references